Yinglang Zhang Selected Research

Neoplasms (Cancer)

1/2023	CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway.
1/2023	circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
1/2022	Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.
1/2021	Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yinglang Zhang Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 01/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
1	Carcinogenesis 01/2023
1	Carcinoma (Carcinomatosis) 01/2021

Drug/Important Bio-Agent (IBA)

3	Circular RNAIBA 01/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	homeobox protein PITX1IBA 01/2021

Therapy/Procedure

1	Immunotherapy 01/2022